Authors:
SEGURA A
APARICIO J
GARCERA S
REYNES G
MONTALAR J
SANTABALLA A
YUSTE A
HERRANZ C
Citation: A. Segura et al., 5-FLUOROURACIL (5-FU) PLUS FOLINIC ACID (FA) FOR PATIENTS WITH ADVANCED COLORECTAL-CANCER (ACRC) TREATED OUTSIDE CLINICAL-TRIALS, Annals of oncology, 9, 1998, pp. 213-213
Authors:
MAESTU I
PASTOR M
GOMEZ J
APARICIO J
MONTALAR J
MUNARRIZ B
REYNES G
HERRANZ C
Citation: I. Maestu et al., SMALL-CELL LUNG-CANCER (SCLC) IN THE ELDERLY - RETROSPECTIVE REVIEW OF 152 PATIENTS, Annals of oncology, 9, 1998, pp. 498-498
Authors:
LOPEZPOUSA A
MONTALAR J
BUESA J
MAUREL J
MARTIN J
CASSINELLO J
SEVILLA I
DELASPENAS R
CRUZ J
BALANA C
Citation: A. Lopezpousa et al., FIRST-LINE DOXORUBICIN AND HIGH-DOSE IFOSFAMIDE (DHI) IN ADVANCED SOFT-TISSUE SARCOMA (STS) PATIENTS - A PHASE-II STUDY OF THE SPANISH GROUP FOR RESEARCH ON SARCOMAS (GEIS), Annals of oncology, 9, 1998, pp. 564-564
Authors:
BARON MG
CONSTENLA M
FRANQUESA R
MONTALAR J
GILI F
CAMPS C
CACHOT P
ORDONEZ A
OZORES R
FEYJOO M
Citation: Mg. Baron et al., EPOETIN-ALPHA IN THE TREATMENT OF ANEMIA IN CANCER-PATIENTS RECEIVINGPLATINUM CHEMOTHERAPY - RESPONSE PREDICTING FACTORS, Annals of oncology, 9, 1998, pp. 695-695
Authors:
MONTALAR J
SANTABALLA A
OLTRA A
SEGURA A
APARICIO A
PASTOR M
Citation: J. Montalar et al., OFLOXACIN WITH OR WITHOUT STIMULATING COLONY-FACTORS IN THE TREATMENTOF NEUTROPENIC FEVER, Annals of oncology, 9, 1998, pp. 724-724
Authors:
SEGURA A
GOMEZCODINA J
PASTOR M
MAESTU I
OLTRA A
APARICIO J
MONTALAR J
HERRANZ C
Citation: A. Segura et al., NON-HODGKINS-LYMPHOMA (NHL) IN THE ELDERLY - AGE IS NOT ALWAYS AN ADVERSE PROGNOSTIC FACTOR, Annals of oncology, 9, 1998, pp. 139-139
Authors:
APARICIO J
SEGURA A
MONTALAR J
VERDEGUER A
CASTEL V
SANCHEZHERAS AB
Citation: J. Aparicio et al., LETTER TO THE EDITOR - SECONDARY CANCERS AFTER EWING SARCOMA AND EWING SARCOMA AS 2ND MALIGNANT NEOPLASM, Medical and pediatric oncology, 30(4), 1998, pp. 259-260
Authors:
APARICIO J
MUNARRIZ B
PASTOR M
VERA FJ
CASTEL V
APARISI F
MONTALAR J
BADAL MD
GOMEZCODINA J
HERRANZ C
Citation: J. Aparicio et al., LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS IN EWINGS-SARCOMA - A MULTIVARIATE-ANALYSIS OF 116 PATIENTS FROM A SINGLE INSTITUTION, Oncology, 55(1), 1998, pp. 20-26
Authors:
ANTON A
CARRATO A
GONZALEZLARRIBA JL
VADEL C
MASUTTI B
MONTALAR J
ARANDA E
LIEPA AM
Citation: A. Anton et al., QUALITY-OF-LIFE ASSESSMENTS OF PATIENTS WITH NONSMALL FELL LUNG-CANCER RECEIVING GEMCITABINE (GEMZAR(TM)) AND CISPLATIN, European journal of cancer, 33, 1997, pp. 43-43
Authors:
MAESTU I
PASTOR M
GOMEZCODINA J
APARICIO J
OLTRA A
HERRANZ C
MONTALAR J
MUNARRIZ B
REYNES G
Citation: I. Maestu et al., PRETREATMENT PROGNOSTIC FACTORS FOR SURVIVAL IN SMALL-CELL LUNG-CANCER - A NEW PROGNOSTIC INDEX AND VALIDATION OF 3 KNOWN PROGNOSTIC INDEXES ON 341 PATIENTS, Annals of oncology, 8(6), 1997, pp. 547-553
Authors:
APARICIO J
OLTRA A
LLORCA C
MONTALAR J
HERRANZ C
GOMEZCODINA J
PASTOR M
MUNARRIZ B
Citation: J. Aparicio et al., RANDOMIZED COMPARISON OF CEFTAZIDIME AND IMIPENEM AS INITIAL MONOTHERAPY FOR FEBRILE EPISODES IN NEUTROPENIC CANCER-PATIENTS, European journal of cancer, 32A(10), 1996, pp. 1739-1743
Authors:
MORATA C
ALFARO A
CHUMILLAS MJ
MONTALAR J
Citation: C. Morata et al., LAMBERT-EATON MYASTHENIC SYNDROME - RESPO NSE TO TREATMENT WITH 3,4-DIAMINOPYRIDINE, Medicina Clinica, 104(4), 1995, pp. 156-156